bitop AG announces Launch of medEctoin® Vaginal Gel in the UK under Bayer's Canesmeno® Brand 

We are proud to announce the launch of bitop’s medEctoin® Vaginal Gel in the United Kingdom, marketed under Bayer's new Canesmeno® brand. This collaboration aims to provide women experiencing vaginal dryness and atrophy with a natural, clinically proven solution to enhance their intimate health and overall well-being. 

medEctoin® Vaginal Gel is formulated with bitop’s 100% natural Ectoin®, a powerful extremolyte known for its cell-protective and inflammation-reducing properties. The gel offers immediate hydration to dry and irritated vaginal mucosa within 10 to 15 minutes, effectively relieving symptoms such as itching and burning sensations. Clinical studies have demonstrated that medEctoin® Vaginal Gel provides significant improvement in symptoms of vaginal atrophy, leading to a better quality of life for women. The product is gynecologically and dermatologically tested, ensuring its suitability for daily use without adverse effects.  

"We are delighted to partner with Bayer to introduce medEctoin® Vaginal Gel under the Canesmeno® brand in the UK," said Eva Galik, CEO at bitop AG. "This collaboration reflects our commitment to delivering natural and effective solutions for women's health. We believe that medEctoin® Vaginal Gel will make a significant difference in the lives of many women seeking relief from vaginal dryness and atrophy." 

The launch of medEctoin® Vaginal Gel under the Canesmeno® brand is part of Bayer's broader initiative to transform menopause support, providing comprehensive solutions to address the diverse needs of women during this life stage.  

For more information about medEctoin® Vaginal Gel, click here.